LCFLX
Price
$14.10
Change
+$0.09 (+0.64%)
Updated
Jul 3 closing price
Net Assets
39.65M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LCFLX vs VVIAX

Header iconLCFLX vs VVIAX Comparison
Open Charts LCFLX vs VVIAXBanner chart's image
Lord Abbett Focused Large Cap Value C
Price$14.10
Change+$0.09 (+0.64%)
VolumeN/A
Net Assets39.65M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LCFLX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LCFLX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCFLX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. LCFLX (39.6M). VVIAX pays higher dividends than LCFLX: VVIAX (2.18) vs LCFLX (0.00). LCFLX was incepted earlier than VVIAX: LCFLX (6 years) vs VVIAX (25 years). LCFLX (2.39) is less costly to investors than VVIAX (0.05). LCFLX is a more actively managed with annual turnover of: 58.00 vs. VVIAX (9.00). LCFLX has a lower initial minimum investment than VVIAX: LCFLX (1500) vs VVIAX (3000). LCFLX annual gain was more profitable for investors over the last year : 15.20 vs. VVIAX (12.03). VVIAX return over 5 years is better than : 80.13 vs. LCFLX (11.77).
LCFLXVVIAXLCFLX / VVIAX
Total Expense Ratio1.710.053,420%
Annual Report Gross Expense Ratio2.390.054,780%
Fund Existence6 years25 years-
Gain YTD8.5456.198138%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets39.6M189B0%
Annual Yield % from dividends0.002.18-
Returns for 1 year15.2012.03126%
Returns for 3 years6.9035.1720%
Returns for 5 years11.7780.1315%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.